We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
-14.88%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$378M
AUM Growth
-$63.9M
Cap. Flow
+$8.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
33.19%
Holding
320
New
19
Increased
77
Reduced
30
Closed
9

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$4.68M
2
META icon
Meta Platforms (Facebook)
META
+$4.36M
3
CAT icon
Caterpillar
CAT
+$4.23M
4
CRWD icon
CrowdStrike
CRWD
+$3.92M
5
SLB icon
SLB Ltd
SLB
+$2.93M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$10.5M
2
APD icon
Air Products & Chemicals
APD
+$6.92M
3
GTLS
Chart Industries
GTLS
+$6.06M
4
CC icon
Chemours
CC
+$2.05M
5
APTV icon
Aptiv
APTV
+$1.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.52%
2 Technology 17.51%
3 Industrials 17.48%
4 Energy 11.3%
5 Financials 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATCO
151
DELISTED
Atlas Corp.
ATCO
$37K 0.01%
3,500
NKE icon
152
Nike
NKE
$63.3B
$36K 0.01%
350
WMB icon
153
Williams Companies
WMB
$86.1B
$36K 0.01%
1,160
+45
+4% +$1.55K
AFL icon
154
Aflac
AFL
$64.5B
$35K 0.01%
634
+4
+0.6% +$236
BAX icon
155
Baxter International
BAX
$14.5B
$34K 0.01%
533
HSY icon
156
Hershey
HSY
$35.7B
$32K 0.01%
150
LHX icon
157
L3Harris
LHX
$51.7B
$32K 0.01%
133
VFF icon
158
Village Farms International
VFF
$236M
$31K 0.01%
11,853
CRSP icon
159
CRISPR Therapeutics
CRSP
$4.88B
$30K 0.01%
500
-1,300
-72% -$76.4K
DLS icon
160
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
$30K 0.01%
507
NVS icon
161
Novartis
NVS
$292B
$30K 0.01%
350
VBK icon
162
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.5B
$30K 0.01%
152
ABT icon
163
Abbott
ABT
$185B
$28K 0.01%
258
+1
+0.4% +$114
ICF icon
164
iShares Select U.S. REIT ETF
ICF
$2.1B
$28K 0.01%
458
YUMC icon
165
Yum China
YUMC
$16.6B
$27K 0.01%
548
+1
+0.2% +$42
IWS icon
166
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$26K 0.01%
260
ORMP icon
167
Oramed Pharmaceuticals
ORMP
$180M
$26K 0.01%
5,627
PG icon
168
Procter & Gamble
PG
$338B
$26K 0.01%
178
XLV icon
169
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$26K 0.01%
206
EWJ icon
170
iShares MSCI Japan ETF
EWJ
$22B
$25K 0.01%
475
FSLR icon
171
First Solar
FSLR
$25B
$25K 0.01%
365
MNSB icon
172
MainStreet Bancshares
MNSB
$166M
$24K 0.01%
1,050
RIO icon
173
Rio Tinto
RIO
$156B
$24K 0.01%
400
DGRO icon
174
iShares Core Dividend Growth ETF
DGRO
$42.9B
$23K 0.01%
490
SG icon
175
Sweetgreen
SG
$703M
$23K 0.01%
2,000
+1,000
+100% +$21.1K

Similar funds

Bourgeon Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bourgeon Capital Management held 320 positions worth $378M, down 14% from $442M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bourgeon Capital Management's Q2 2022 filing shows 19 new, 77 increased, 30 reduced and 9 closed positions. Its largest new stake was CrowdStrike: 86,556 shares worth $3.65M. The largest sale was iShares Gold Trust, an estimated $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • Bourgeon Capital Management's largest Q2 2022 buy was CrowdStrike: 86,556 shares worth $3.65M.
  • Bourgeon Capital Management added most to RTX Corp in Q2 2022, an estimated $4.68M increase.
  • Bourgeon Capital Management's biggest Q2 2022 reduction was iShares Gold Trust, cutting an estimated $10.5M.
  • Bourgeon Capital Management fully exited Air Products & Chemicals in Q2 2022, selling an estimated $6.92M.
  • Bourgeon Capital Management's ten largest holdings make up 33% of its $378M portfolio in Q2 2022.
  • Bourgeon Capital Management opened 19 new positions and closed 9 in Q2 2022.
  • Bourgeon Capital Management's portfolio value fell 14% quarter-over-quarter to $378M.

Based on Bourgeon Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.